About Invizius
Invizius is a company based in Edinburgh (United Kingdom) founded in 2018.. Invizius has raised $13.09 million across 6 funding rounds from investors including Mercia, Downing and Scottish Enterprise. The company has 12 employees as of December 31, 2021. Invizius offers products and services including H-Guard and PspCN. Invizius operates in a competitive market with competitors including VenoStent, Renal Solutions, Redsense Medical, Health Line International Corporation and Peace and Quiet Care, among others.
- Headquarter Edinburgh, United Kingdom
- Employees 12 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Invizius Limited
- Date of Incorporation 26 Jan, 2018
- Jurisdiction EDINBURGH, UNITED KINGDOM
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$13.09 M (USD)
in 6 rounds
-
Latest Funding Round
$1.27 M (USD), Series A
Sep 23, 2024
-
Investors
Mercia
& 9 more
-
Employee Count
12
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Invizius
Invizius offers a comprehensive portfolio of products and services, including H-Guard and PspCN. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Complement therapy for patients on dialysis and extracorporeal circuits.
Technology to supercharge natural regulators for enhanced efficacy.
Funding Insights of Invizius
Invizius has successfully raised a total of $13.09M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $1.27 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series A — $1.3M
-
First Round
First Round
(02 May 2018)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2024 | Amount | Series A - Invizius | Valuation | Mercia | |
| Mar, 2022 | Amount | Grant - Invizius | Valuation |
investors |
|
| May, 2021 | Amount | Series A - Invizius | Valuation | Mercia , Downing |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Invizius
Invizius has secured backing from 10 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Mercia, Downing and Scottish Enterprise. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
UK venture capital investments are managed by Calculus Capital.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Inheritance tax relief, funds, and bonds are provided across sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Invizius
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Invizius
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Invizius Comparisons
Competitors of Invizius
Invizius operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as VenoStent, Renal Solutions, Redsense Medical, Health Line International Corporation and Peace and Quiet Care, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Shape memory polymer stents are developed for vascular surgery applications.
|
|
| domain | founded_year | HQ Location |
Sorbents for renal replacement therapy are developed using regenerative technology.
|
|
| domain | founded_year | HQ Location |
Blood access is monitored during hemodialysis via alarm systems.
|
|
| domain | founded_year | HQ Location |
Contract Manufacturer of Dialysis products, Also sells own product lines.
|
|
| domain | founded_year | HQ Location |
Develops innovative renal dialysis machines with soundproof boxes.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Invizius
Frequently Asked Questions about Invizius
When was Invizius founded?
Invizius was founded in 2018.
Where is Invizius located?
Invizius is headquartered in Edinburgh, United Kingdom. It is registered at Edinburgh, Scotland, United Kingdom.
Who is the current CEO of Invizius?
Richard Boyd is the current CEO of Invizius.
Is Invizius a funded company?
Invizius is a funded company, having raised a total of $13.09M across 6 funding rounds to date. The company's 1st funding round was a Series A of $7.37M, raised on May 02, 2018.
How many employees does Invizius have?
As of Dec 31, 2021, the latest employee count at Invizius is 12.
What does Invizius do?
Invizius was founded in 2018 in Edinburgh, United Kingdom, within the medical devices sector focused on dialysis technology. Priming solutions for hemodialyzers are developed by the company, with H-Guard as the primary product under development. This solution incorporates a hemocompatible coating to mitigate foreign body reactions in blood during dialysis procedures. Applications target hollow fibers in dialyzers, where membrane inflammation in patients blood is addressed through reduced interactions.
Who are the top competitors of Invizius?
Invizius's top competitors include VenoStent, Redsense Medical and Renal Solutions.
What products or services does Invizius offer?
Invizius offers H-Guard and PspCN.
Who are Invizius's investors?
Invizius has 10 investors. Key investors include Mercia, Downing, Scottish Enterprise, Calculus Capital, and Solvay.